FTC deal over insulin prices forces Express Scripts to overhaul policies

Elizabeth Casolo / beckershospitalreview - The Federal Trade Commission reached a settlement with Cigna’s Express Scripts in a case over alleged inflation of insulin prices, according to a Feb. 4 agency news release. Under the settlement, Express Scripts must keep drug manufacturer compensation de…

AI Summary: Federal regulators reached a settlement with Express Scripts amid long‐standing allegations that the pharmacy benefit manager overcharged for insulin. The deal forces sweeping policy revisions to curb price inflation and protect patients from rising costs, following years of regulatory scrutiny over insulin rebate practices.

---

Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61

Related Stories

---

Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

AbbVie sues over Botox selection in Medicare price negotiations / 3 months

HHS drops 340B pilot following court rulings / 3 months

HHS scraps 340B rebate pilot following court rulls / 3 months

Judge blocks 340B drug pricing pilot program implementation / 4 months

CMS Unveils Medicaid Drug Pricing Model with Most-Favored Nation Approach / 6 months

Optum Rx/Caremark and FTC edge toward settlement in insulin case / 2 months

Life-extending prostate cancer drug to be offered to thousands in England / 4 months